Insights

Professional

Practice

Industry

Region

Client Alerts 4 results

Client Alert | 5 min read | 01.27.25

Potential Consumer Litigation Impacts from FDA’s Proposed Rule on Standardized Testing for Talc-Containing Cosmetics

For years, consumers have initiated legal actions against cosmetic companies alleging a causal relationship between the use of certain cosmetic products containing talc (such as baby powder) and the development of various cancers, commonly mesothelioma and ovarian cancer, with varied results. Below, we discuss a recent proposed rule from FDA proposing asbestos testing for cosmetics containing talc and potential impacts on ongoing and new consumer litigation.

...

Client Alert | 3 min read | 10.29.24

The Ink is Dry: FDA Issues Final Guidance for Tattoo Industry

On October 25, 2024, FDA issued final guidance to the tattoo industry on the preparation, packing and holding of tattoo inks aimed at preventing the risk of microbial contamination. FDA is getting involved because tattoo ink is considered a cosmetic product regulated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).

...

Client Alert | 1 min read | 11.09.23

FDA Delays Enforcement of MoCRA Facility Registration and Product Listing Requirements

On November 8, 2023, the U.S. Food and Drug Administration (FDA) issued guidance on its intent to delay enforcement of the facility registration and product listing requirements set forth in in the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) for an additional six months (until July 1, 2024) to allow cosmetics companies enough time to submit facility registration and product listing information.

...